Entries from India Chemicals Blog tagged with 'fine chemicals'
Not so fine anymore?
News is slowly trickling in of Indian pharmaceutical and fine chemical companies shutting down facilities that were acquired with great zeal during the 2005-08 overseas acquisition drive. Shasun has decided to shut its facility at Newbie in Scotland and is...
Matrix mulls Docpharma sale
Have Indian fine chemical and pharma companies been too hasty in their global acquisitions? I had been hearing talk of some companies running into integration problems or having second thoughts on perceived benefits of their acquisitions. But today’s report that...
Testing times for CRAMS
Business is booming in India’s custom research and manufacturing services (CRAMS) industry thanks to the country's strong process chemistry skills, low operational costs and the availability of a skilled workforce. Frost & Sullivan values the Indian CRAMS market at $890m,...
CRAMs comes with challenges
India’s success in the global custom research and manufacturing services space (CRAMS) is well documented. And the untapped potential is huge especially as western pharmaceutical companies remain under pressure to cut costs. According to one estimate, the global manufacturing outsourcing...
Indian chemicals score on CRAMS
Jubiliant Organosys' announcement that it has clinched deals worth $60m from global life science majors reinforces India's growing strength in the custom research and manufacturing services (CRAMS) business. Rising competition and research costs are supporting the CRAMS outsourcing wave and...
Feed Subscription
If you use an RSS reader, you can subscribe to a feed of all future entries tagged 'fine chemicals'. [What is this?]
